Ropivacaine HCL (PF) 0.2% (2mg/mL) 100 mL Cassette Rx Only Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226 NDC 7025006301
Published November 1, 2017 · Recall initiated: October 10, 2017
Summary
FDA records drug Class II recall D-0024-2018, published November 1, 2017 and initiated October 10, 2017. Recalling firm: Banner Pharmacy Services, LLC; Status: Terminated; Reported quantity: 2173 cassettes; Lot: Lot #: 041117S2, Exp 10/11/2017; 041817S3, Exp 10/18/2017; 042517S3, 10/25/2017; 050117S2, Exp 10/3102/17; 053017S3, Exp 11/29/2017; 060117S3, Exp 12/1/2017; 060617S3, Exp 12/6/2017; 061217S1, 12/12/2017; 062017S3, Exp 12/20/2017; 062717S2, Exp 12/27/2017; 062817S3, Exp 12/28/2017; 071117S2, Exp 1/10/2018; 071817S3, Exp 1/17/2018; 072117S3, Exp 1/20/2018; 072417S3, Exp 1/23/2018; 072517S3, Exp 1/24/2018; 080217S4, Exp 2/1/2018; 081117S3, Exp 2/10/2018; 081817S2, Exp 2/17/2018; 082317S4, Exp 2/22/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Banner Pharmacy Services, LLC
- Distributor
- Nationwide within the US
- Lot
- Lot #: 041117S2, Exp 10/11/2017; 041817S3, Exp 10/18/2017; 042517S3, 10/25/2017; 050117S2, Exp 10/3102/17; 053017S3, Exp 11/29/2017; 060117S3, Exp 12/1/2017; 060617S3, Exp 12/6/2017; 061217S1, 12/12/2017; 062017S3, Exp 12/20/2017; 062717S2, Exp 12/27/2017; 062817S3, Exp 12/28/2017; 071117S2, Exp 1/10/2018; 071817S3, Exp 1/17/2018; 072117S3, Exp 1/20/2018; 072417S3, Exp 1/23/2018; 072517S3, Exp 1/24/2018; 080217S4, Exp 2/1/2018; 081117S3, Exp 2/10/2018; 081817S2, Exp 2/17/2018; 082317S4, Exp 2/22/2018.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVANCOmycin 1.25 grams added to 0.9% Sodium Chloride 500 mL bag, Rx Only, Banner Health Compounding PharmacyNovember 1, 2017
- FDADiltiazem HCL 125 mg added to 0.9% Sodium Chloride 100 ml bag, 125 mL bag, Rx Only, Banner Health CompoundingNovember 1, 2017
- FDANorepinephrine Bitartrate16 mg added to 0.9% Sodium Chloride 250 mL bag, Rx Only, Banner Health CompoundingNovember 1, 2017
- FDAHydromorphone HCl 10 mg (0.2mg/ml) 50 mL syringes in 0.9% Sodium Chloride, Rx Only, Banner Health CompoundingNovember 1, 2017
- FDAOXYtocin 30 units added to 0.9% Sodium Chloride 500 mL bag, Rx Only, Banner Health Compounding Pharmacy 7300 WNovember 1, 2017
- FDASuccinylcholine 200 mg/10 mL Syringe, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler,November 1, 2017
Questions about this recall
Was Ropivacaine HCL (PF) 0.2% (2mg/mL) 100 mL Cassette Rx Only Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226 NDC 7025006301 recalled?
Yes. FDA published recall D-0024-2018 on November 1, 2017. Reported hazard: Lack of Assurance of Sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter